Icagen, Inc.
Research company · Durham, North Carolina, United States
Icagen, Inc. is a research company headquartered in Durham, North Carolina, United States. It has received 12 US government small-business research awards (SBIR/STTR) from health agencies, $6.6 million in total, most recently in 2015. It has reported private securities offerings to the US SEC, most recently $7.3 million sold in a notice filed in 2018.
What does Icagen do?
US government research funding
12 SBIR/STTR small-business research awards from US health agencies, $6.6 million in total (1996 to 2015).
Private fundraising reported to the SEC
11 Form D notices; the most recent reported $7.3 million sold (2018).
Frequently asked questions about Icagen
Where is Icagen headquartered?
Icagen, Inc. is headquartered in Durham, North Carolina, United States.
What does Icagen do?
Icagen, Inc. is a research company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Maxcyte, Inc.Rockville, Maryland, United States
- Absci CorpVancouver, Washington, United States
- SomaLogic, Inc.Boulder, Colorado, United States
- bioAffinity Technologies, Inc.San Antonio, Texas, United States
- iSpecimen Inc.Woburn, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.